TABLE 4.
Stepwise multiple linear regression analysis of the entry of meropenem into ventricular CSF
| Dependent variable | Independent variable | R2 | F value | P value |
|---|---|---|---|---|
| AUCCSF | AUCS | 0.87 | 53.4 | 0.0001 |
| QAlb | 0.97 | 100.3 | <0.00005 | |
| CSF leukocyte density | 0.98 | 131.0 | <0.00005 | |
| CmaxCSF | AUCS | 0.64 | 14.2 | 0.0055 |
| CSF leukocyte density | 0.94 | 59.2 | <0.00005 | |
| QAlb | 0.97 | 69.5 | <0.00005 |